# US 2026/0098295 A1 · Sequencing methods and compositions for prenatal diagnoses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0098295 A1
- Document ID: US20260098295A1
- Status: Published application
- Kind: A1
- Application number: 19/414,578
- Filed: 2025-12-10
- Published: 2026-04-09
- Earliest claimed: 2010-01-19
- Assignees: Verinata Health, Inc.
- Applicants: Verinata Health, Inc.
- Inventors: Richard P. Rava; Manjula Chinnappa; David A. Comstock; Gabrielle Heilek; Brian Kent Rhees
- Web page: https://patentgrep.com/patent/US20260098295A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- G16B 20/10: Ploidy or copy number detection
- G16B 30/10: Sequence alignment; Homology search
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C12Q 2600/112: Disease subtyping, staging or classification
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The invention provides methods for determining aneuploidy and/or fetal fraction in maternal samples comprising fetal and maternal ctDNA by massively parallel sequencing. The method comprises a novel protocol for preparing sequencing libraries that unexpectedly improves the quality of library DNA while expediting the process of analysis of samples for prenatal diagnoses.

## Claims

### Claim 1

A method for determining a fetal chromosomal aneuploidy in a maternal sample comprising a mixture of fetal and maternal nucleic acids molecules, said method comprising:
(a) preparing a sequencing library from said mixture of fetal and maternal nucleic acid molecules; wherein preparing said library comprises the consecutive steps of end-repairing, dA-tailing and adaptor ligating said nucleic acids;
(b) sequencing at least a portion of said nucleic acid molecules, thereby obtaining sequence information for a plurality of fetal and maternal nucleic acid molecules of a maternal sample;
(c) using the sequence information to obtain a chromosome dose for an aneuploid chromosome; and
(d) comparing said chromosome dose to at least one threshold value, and thereby identifying the presence or absence of fetal aneuploidy

### Claim at position 2

2-43. (canceled)
